168 related articles for article (PubMed ID: 28468587)
21. Epigenetic silencing of miR-137 is a frequent event in gastric carcinogenesis.
Steponaitiene R; Kupcinskas J; Langner C; Balaguer F; Venclauskas L; Pauzas H; Tamelis A; Skieceviciene J; Kupcinskas L; Malfertheiner P; Link A
Mol Carcinog; 2016 Apr; 55(4):376-86. PubMed ID: 25663388
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes.
Wen X; Wu JQ; Peng W; Feng JF; Tang JH
Oncol Rep; 2015 Jul; 34(1):203-10. PubMed ID: 25998046
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-381 inhibits the metastasis of gastric cancer by targeting TMEM16A expression.
Cao Q; Liu F; Ji K; Liu N; He Y; Zhang W; Wang L
J Exp Clin Cancer Res; 2017 Feb; 36(1):29. PubMed ID: 28193228
[TBL] [Abstract][Full Text] [Related]
24. Emerging Role of miRNAs in the Drug Resistance of Gastric Cancer.
Riquelme I; Letelier P; Riffo-Campos AL; Brebi P; Roa JC
Int J Mol Sci; 2016 Mar; 17(3):424. PubMed ID: 27011182
[TBL] [Abstract][Full Text] [Related]
25. Knockdown of long non-coding RNA HOTAIR inhibits cisplatin resistance of gastric cancer cells through inhibiting the PI3K/Akt and Wnt/β-catenin signaling pathways by up-regulating miR-34a.
Cheng C; Qin Y; Zhi Q; Wang J; Qin C
Int J Biol Macromol; 2018 Feb; 107(Pt B):2620-2629. PubMed ID: 29080815
[TBL] [Abstract][Full Text] [Related]
26. SLC34A2 regulates miR-25-Gsk3β signaling pathway to affect tumor progression in gastric cancer stem cell-like cells.
Zhang L; Guo X; Zhang L; Yang F; Qin L; Zhang D; Qin Y
Mol Carcinog; 2018 Mar; 57(3):440-450. PubMed ID: 29178392
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA dysregulation in gastric cancer.
Pan HW; Li SC; Tsai KW
Curr Pharm Des; 2013; 19(7):1273-84. PubMed ID: 23092346
[TBL] [Abstract][Full Text] [Related]
28. MicroRNA-495-3p functions as a tumor suppressor by regulating multiple epigenetic modifiers in gastric carcinogenesis.
Eun JW; Kim HS; Shen Q; Yang HD; Kim SY; Yoon JH; Park WS; Lee JY; Nam SW
J Pathol; 2018 Jan; 244(1):107-119. PubMed ID: 28991363
[TBL] [Abstract][Full Text] [Related]
29. microRNA: The Impact on Cancer Stemness and Therapeutic Resistance.
Jiao X; Qian X; Wu L; Li B; Wang Y; Kong X; Xiong L
Cells; 2019 Dec; 9(1):. PubMed ID: 31861404
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-27a contributes to the malignant behavior of gastric cancer cells by directly targeting PH domain and leucine-rich repeat protein phosphatase 2.
Ding L; Zhang S; Xu M; Zhang R; Sui P; Yang Q
J Exp Clin Cancer Res; 2017 Mar; 36(1):45. PubMed ID: 28327189
[TBL] [Abstract][Full Text] [Related]
31. Molecular pathology of gastric cancer: research and practice.
Yasui W; Sentani K; Sakamoto N; Anami K; Naito Y; Oue N
Pathol Res Pract; 2011 Oct; 207(10):608-12. PubMed ID: 22005013
[TBL] [Abstract][Full Text] [Related]
32. Significance of microRNA 21 in gastric cancer.
Sekar D; Krishnan R; Thirugnanasambantham K; Rajasekaran B; Islam VI; Sekar P
Clin Res Hepatol Gastroenterol; 2016 Nov; 40(5):538-545. PubMed ID: 27179559
[TBL] [Abstract][Full Text] [Related]
33. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance.
Liu K; Li G; Fan C; Diao Y; Wu B; Li J
J Int Med Res; 2012; 40(2):467-74. PubMed ID: 22613407
[TBL] [Abstract][Full Text] [Related]
34. LGR5 Is a Gastric Cancer Stem Cell Marker Associated with Stemness and the EMT Signature Genes NANOG, NANOGP8, PRRX1, TWIST1, and BMI1.
Wang B; Chen Q; Cao Y; Ma X; Yin C; Jia Y; Zang A; Fan W
PLoS One; 2016; 11(12):e0168904. PubMed ID: 28033430
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of MicroRNA Deregulation and MicroRNA Targets in Gastric Cancer.
Irmak-Yazicioglu MB
Oncol Res Treat; 2016; 39(3):136-9. PubMed ID: 27031864
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-340 promotes the tumor growth of human gastric cancer by inhibiting cyclin G2.
Yin G; Zhou H; Xue Y; Yao B; Zhao W
Oncol Rep; 2016 Aug; 36(2):1111-8. PubMed ID: 27374211
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-27b, microRNA-101 and microRNA-128 inhibit angiogenesis by down-regulating vascular endothelial growth factor C expression in gastric cancers.
Liu HT; Xing AY; Chen X; Ma RR; Wang YW; Shi DB; Zhang H; Li P; Chen HF; Li YH; Gao P
Oncotarget; 2015 Nov; 6(35):37458-70. PubMed ID: 26460960
[TBL] [Abstract][Full Text] [Related]
38. LncRNA SNHG6 is Associated with Poor Prognosis of Gastric Cancer and Promotes Cell Proliferation and EMT through Epigenetically Silencing p27 and Sponging miR-101-3p.
Yan K; Tian J; Shi W; Xia H; Zhu Y
Cell Physiol Biochem; 2017; 42(3):999-1012. PubMed ID: 28683446
[TBL] [Abstract][Full Text] [Related]
39. Emerging role of microRNAs in modulating endothelin-1 expression in gastric cancer.
Tsai KW; Hu LY; Chen TW; Li SC; Ho MR; Yu SY; Tu YT; Chen WS; Lam HC
Oncol Rep; 2015 Jan; 33(1):485-93. PubMed ID: 25394359
[TBL] [Abstract][Full Text] [Related]
40. LncRNA-RMRP promotes carcinogenesis by acting as a miR-206 sponge and is used as a novel biomarker for gastric cancer.
Shao Y; Ye M; Li Q; Sun W; Ye G; Zhang X; Yang Y; Xiao B; Guo J
Oncotarget; 2016 Jun; 7(25):37812-37824. PubMed ID: 27192121
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
